Wednesday, December 7

The genes of the mother and father ‘fight’ over the nutrition of the fetus during pregnancy


The fetus receives nourishment through the blood vessels of the placenta, a specialized organ that contains cells from both the baby and the mother. As it grows, its nutritional demand is greater.

Ten False Fertility Topics You Shouldn’t Tell Those Who Are Looking For Pregnancy

Know more

Between 10 and 15% of babies show low growth in the womb, often due to less development of the placental vasculature. In humans, these blood vessels expand dramatically between mid and late gestation, when they reach a total length of approximately 200 miles.

Babies who are too big or too small are more likely to suffer or even die at birth, and have a higher risk of developing diabetes and heart problems in adulthood

In a study published today in Developmental Cell, a team led by scientists from the University of Cambridge (UK) used genetically modified mice to show how the fetus produces a signal that encourages the growth of blood vessels within the placenta. This signal also causes modifications in other placental cells to allow more nutrients from the mother to reach the baby.

“As it grows, the fetus needs food from its mother, and healthy blood vessels in the placenta are essential to obtain the adequate amount of nutrients it needs,” explains Ionel Sandovici, first author of the work.

“We have identified one of the ways that the fetus uses to communicate with the placenta and cause the correct expansion of these blood vessels. When this communication is interrupted, the blood vessels do not develop properly and the baby will have difficulty obtaining all the food that you need, “adds the researcher.

IGF2 hormone and baby growth

The scientific team discovered that the fetus sends a signal known as IGF2 – a peptide hormone that is involved in the regulation of proliferation, growth, migration, differentiation and survival of cells – that reaches the placenta through the cord umbilical.

In humans, IGF2 levels progressively increase after 29 weeks of gestation: a large contribution is associated with excessive growth and an insufficient amount with poor growth

In humans, IGF2 levels progressively increase between 29 weeks’ gestation and term: a large supply of IGF2 is associated with excessive growth, while an insufficient amount of IGF2 is associated with poor growth.

Babies that are too big or too small are more likely to suffer or even die at birth, and are at higher risk of developing diabetes and heart problems in adulthood.

“We have known for a long time that IGF2 promotes the growth of the organs where it is produced. In this study, we have shown that IGF2 acts like a classic hormone: it is produced by the fetus, passes into fetal blood and, through the cord umbilical, to the placenta, where it acts “, adds the scientist.

Battle of the sexes in the genome

In mice, the response to IGF2 in the blood vessels of the placenta is mediated by another protein, called IGF2R. The two genes that produce IGF2 and IGF2R are imprinted genes, that is, they are expressed in a specific way according to the sex of the parent. In this case, only the copy of the IGF2 gene inherited from the father and that of IGF2R inherited from the mother are active.

“One theory about imprinted genes is that the genes expressed by the father are ‘greedy and selfish’. They want to extract the maximum possible resources from the mother. But the genes expressed by the mother act as a counterweight to balance these demands,” he reveals Miguel Constância, co-author of the study.

The father’s gene stimulates the fetus’s needs for larger blood vessels and more nutrients, while the mother’s gene in the placenta tries to control the amount of food provided by Miguel Constância, co-author of the study

“The father’s gene stimulates the fetus’ needs for larger blood vessels and more nutrients, while the mother’s gene in the placenta tries to control the amount of food it provides. There is a tug of war, a battle of the sexes on a scale. of the genome “, emphasizes the expert.

The team says their findings will provide a better understanding of how the baby, the placenta, and the mother communicate with each other during pregnancy. This, in turn, could lead to ways to measure fetal IGF2 levels and find ways to use medications to normalize those levels or promote normal development of the placental vasculature.



www.eldiario.es